Strs Ohio X Biotech Inc. Transaction History

Strs Ohio

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 25, 2022	SELL	$5.13 - $9.2 $105,165 - $188,599	-20,500 Closed	0 $0
Q3 2021 Oct 22, 2021	BUY	$12.95 - $18.24 $40,145 - $56,543	3,100 Added 17.82%	20,500 $265,000
Q2 2021 Jul 26, 2021	SELL	$15.83 - $17.84 $42,741 - $48,168	-2,700 Reduced 13.43%	17,400 $288,000
Q3 2020 Dec 14, 2020	SELL	$13.97 - $21.16 $201,168 - $304,704	-14,400 Reduced 41.74%	20,100 $383,000
Q2 2020 Jul 23, 2020	BUY	$10.39 - $16.07 $135,142 - $209,022	13,007 Added 60.52%	34,500 $472,000
Q1 2020 Apr 23, 2020	SELL	$8.89 - $24.94 $95,185 - $267,032	-10,707 Reduced 33.25%	21,493 $228,000
Q4 2019 Jan 24, 2020	SELL	$8.33 - $19.95 $124,950 - $299,250	-15,000 Reduced 31.78%	32,200 $601,000
Q2 2019 Jul 25, 2019	BUY	$6.99 - $11.27 $329,928 - $531,944	47,200 New	47,200 $357,000

4.87M

Ticker XBIT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 30,439,300
Market Cap $203M
Description
XBiotech Inc., a biopharmaceutical company, discovers, develops, and commercializes True Human monoclonal antibodies for treating various diseases. The company focuses on developing a pipeline of product candidates targeting both inflammatory and infectious diseases. It is also developing interleukin-1 alpha therapies to treat variety of medical...

Get notified when there are updates to the investment portfolio of Strs Ohio, based on Form 13F filings with the SEC.

Stay updated on Strs Ohio with notifications on news.